Advertisement

Neonatal ECMO survivors: the late emergence of hidden morbidities – an unmet need for long-term follow-up

  • Aparna Hoskote
    Correspondence
    Corresponding author. Consultant in Cardiac Intensive Care Honorary Associate Professor, UCL Institute of Cardiovascular Science Great Ormond Street Hospital for Children NHS Foundation Trust London WC1N 3JH, UK Tel.: +44 2074059200; fax: +44 2078138262
    Affiliations
    Cardiac Intensive Care Unit, Heart and Lung Directorate, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK
    Search for articles by this author
  • Maayke Hunfeld
    Affiliations
    Intensive Care and Department of Pediatric Surgery, Erasmus MC-Sophia Children’s Hospital, University Medical Center Rotterdam, the Netherlands
    Search for articles by this author
  • Maura O’Callaghan
    Affiliations
    Cardiac Intensive Care Unit, Heart and Lung Directorate, Great Ormond Street Hospital for Children NHS Foundation Trust, London WC1N 3JH, UK
    Search for articles by this author
  • Hanneke IJsselstijn
    Affiliations
    Intensive Care and Department of Pediatric Surgery, Erasmus MC-Sophia Children’s Hospital, University Medical Center Rotterdam, the Netherlands
    Search for articles by this author
Published:November 24, 2022DOI:https://doi.org/10.1016/j.siny.2022.101409
      Since the initiation of Extracorporeal Life Support Organization (ELSO) Registry in 1989, more than 47,000 neonates treated with extracorporeal membrane oxygenation (ECMO) have been registered worldwide with an overall survival rate of 65% to transfer or hospital discharge.

      ELSO, https://www.elso.org/Registry/ELSOLiveRegistryDashboard.aspx.

      A brief overview of the last 5-year ELSO Registry data reveals an important shift in the indication for neonatal ECMO (Figure 1A and 1B) with a notable increase in neonatal cardiac ECMO (44% to 52%, respectively).

      ELSO, https://www.elso.org/Registry/ELSOLiveRegistryDashboard.aspx.

      Figure 1
      Figure 1Change in indication for neonatal ECMO treatment over the years

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Seminars in Fetal and Neonatal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. ELSO, https://www.elso.org/Registry/ELSOLiveRegistryDashboard.aspx.

        • Howell H.B.
        • et al.
        Neurodevelopmental outcomes of children with congenital heart disease: A review.
        Curr Probl Pediatr Adolesc Health Care. 2019; 49100685
        • Marino B.S.
        • et al.
        Neurodevelopmental outcomes in children with congenital heart disease: evaluation and management: a scientific statement from the American Heart Association.
        Circulation. 2012; 126: 1143-1172
        • IJsselstijn H.
        • et al.
        Improving Long-Term Outcomes After Extracorporeal Membrane Oxygenation: From Observational Follow-Up Programs Toward Risk Stratification.
        Front Pediatr. 2018; 6: 177
        • Ijsselstijn H.
        • et al.
        Extracorporeal Life Support Organization (ELSO) Guidelines for Follow-up After Neonatal and Pediatric Extracorporeal Membrane Oxygenation.
        Asaio j. 2021; 67: 955-963
        • Sadhwani A.
        • et al.
        Early Neurodevelopmental Outcomes in Children Supported with ECMO for Cardiac Indications.
        Pediatr Cardiol. 2019; 40: 1072-1083
        • Hofhuis W.
        • et al.
        Prospective longitudinal evaluation of lung function during the first year of life after extracorporeal membrane oxygenation*.
        Pediatric Critical Care Medicine. 2011; 12: 159-164
        • Beardsmore C.S.
        • et al.
        How does the changing profile of infants who are referred for extracorporeal membrane oxygenation affect their overall respiratory outcome?.
        Pediatrics. 2007; 120: e762-e768
        • Beardsmore C.
        • et al.
        Respiratory function in survivors of the United Kingdom extracorporeal membrane oxygenation trial.
        American journal of respiratory and critical care medicine. 2000; 161: 1129-1135
        • Boykin A.R.
        • et al.
        Cardiopulmonary outcome of neonatal extracorporeal membrane oxygenation at ages 10–15 years.
        Critical care medicine. 2003; 31: 2380-2384
        • Majaesic C.M.
        • et al.
        Clinical correlations and pulmonary function at 8 years of age after severe neonatal respiratory failure.
        Pediatric pulmonology. 2007; 42: 829-837
        • Hamutcu R.
        • et al.
        Long-term pulmonary sequelae in children who were treated with extracorporeal membrane oxygenation for neonatal respiratory failure.
        Pediatrics. 2004; 114: 1292-1296
        • Spoel M.
        • et al.
        Prospective longitudinal evaluation of lung function during the first year of life after repair of congenital diaphragmatic hernia.
        Pediatric Critical Care Medicine. 2012; 13: e133-e139
        • Toussaint-Duyster L.C.C.
        • et al.
        Lung function in school-aged congenital diaphragmatic hernia patients; a longitudinal evaluation.
        Pediatr Pulmonol. 2019; 54: 1257-1266
      2. Ijsselstijn, H. and A.F.J. van Heijst. Long-term outcome of children treated with neonatal extracorporeal membrane oxygenation: Increasing problems with increasing age. in Seminars in perinatology. 2014. Elsevier.

        • Spoel M.
        • et al.
        Pulmonary ventilation and micro-structural findings in congenital diaphragmatic hernia.
        Pediatr Pulmonol. 2016; 51: 517-524
        • van der Cammen-van Zijp M.H.M.
        • et al.
        Deterioration of exercise capacity after neonatal extracorporeal membrane oxygenation.
        European Respiratory Journal. 2011; 38: 1098-1104
        • Toussaint-Duyster L.C.C.
        • et al.
        Congenital diaphragmatic hernia and exercise capacity, a longitudinal evaluation.
        Pediatr Pulmonol. 2019; 54: 628-636
        • Toussaint-Duyster L.C.C.
        • et al.
        Improvement of exercise capacity following neonatal respiratory failure: A randomized controlled trial.
        Scand J Med Sci Sports. 2020; 30: 662-671
        • van der Cammen-van Zijp M.H.
        • et al.
        Motor performance after neonatal extracorporeal membrane oxygenation: a longitudinal evaluation.
        Pediatrics. 2014; 134: e427-e435
        • de Munck S.
        • et al.
        Persisting Motor Function Problems in School-Aged Survivors of Congenital Diaphragmatic Hernia.
        Front Pediatr. 2021; 9729054
        • Toussaint L.C.
        • et al.
        Perceived Motor Competence Differs From Actual Performance in 8-Year-Old Neonatal ECMO Survivors.
        Pediatrics. 2016; 137: e20152724
        • Toussaint-Duyster L.C.C.
        • et al.
        A parent-reported standardised checklist is not sensitive to screen for motor problems at school age following neonatal critical illness.
        Acta Paediatr. 2020; 109: 1801-1806
        • Hansrivijit P.
        • et al.
        Acute Kidney Injury in Pediatric Patients on Extracorporeal Membrane Oxygenation: A Systematic Review and Meta-analysis.
        Medicines (Basel). 2019; 6
        • Clark B.G.
        • et al.
        Screening for language delay after life-saving therapies in term-born infants.
        Cardiol Young. 2016; 26: 1343-1351
        • Partridge E.A.
        • et al.
        Incidence and factors associated with sensorineural and conductive hearing loss among survivors of congenital diaphragmatic hernia.
        J Pediatr Surg. 2014; 49 (; discussion 894): 890-894
      3. Zwiers, A.J.M., et al., CKD and hypertension during long-term follow-up in children and adolescents previously treated with extracorporeal membrane oxygenation. Clinical Journal of the American Society of Nephrology, 2014: p. CJN. 02890314.

        • Kakat S.
        • et al.
        The 1-Year Follow-Up Clinic for Neonates and Children After Respiratory Extracorporeal Membrane Oxygenation Support: A 10-Year Single Institution Experience.
        Pediatr Crit Care Med. 2017; 18: 1047-1054
      4. Bulas, D. and P. Glass. Neonatal ECMO: neuroimaging and neurodevelopmental outcome. in Seminars in perinatology. 2005. Elsevier.

        • Graziani L.J.
        • Gringlas M.
        • Baumgart S.
        Cerebrovascular complications and neurodevelopmental sequelae of neonatal ECMO.
        Clin Perinatol. 1997; 24: 655-675
        • Lazar E.L.
        • et al.
        Neuroimaging of brain injury in neonates treated with extracorporeal membrane oxygenation: lessons learned from serial examinations.
        J Pediatr Surg. 1994; 29 (; discussion 190-1): 186-190
        • Polito A.
        • B.C.
        • Wypij D.
        • Rycus P.T.
        • Netto R.
        • Cogo P.E.
        • Thiagarajan R.R.
        Neurologic complications in neonatessupported with extracorporeal membrane oxygenation. An analysis of ELSO registry data.
        Intensive Care Med. 2013; 39: 1594-1601
        • Werho D.K.
        • et al.
        Epidemiology of Stroke in Pediatric Cardiac Surgical Patients Supported With Extracorporeal Membrane Oxygenation.
        Ann Thorac Surg. 2015; 100: 1751-1757
        • Dalton H.J.
        • et al.
        Factors Associated with Bleeding and Thrombosis in Children Receiving Extracorporeal Membrane Oxygenation.
        Am J Respir Crit Care Med. 2017; 196: 762-771
        • LaRovere K.L.
        • et al.
        Patterns of Head Computed Tomography Abnormalities During Pediatric Extracorporeal Membrane Oxygenation and Association With Outcomes.
        Pediatr Neurol. 2017; 73: 64-70
        • Abend N.S.
        • Dlugos D.J.
        • Clancy R.R.
        A review of long-term EEG monitoring in critically ill children with hypoxic-ischemic encephalopathy, congenital heart disease, ECMO, and stroke.
        J Clin Neurophysiol. 2013; 30: 134-142
        • Wien M.A.
        • et al.
        Patterns of Brain Injury in Newborns Treated with Extracorporeal Membrane Oxygenation.
        AJNR Am J Neuroradiol. 2017; 38: 820-826
      5. Cvetkovic, M., et al., International survey of neuromonitoring and neurodevelopmental outcome in children and adults supported on extracorporeal membrane oxygenation in Europe. Perfusion, 2021: p. 2676591211042563.

        • Bembea M.M.
        • et al.
        Neuromonitoring During Extracorporeal Membrane Oxygenation: A Systematic Review of the Literature.
        Pediatr Crit Care Med. 2015; 16: 558-564
        • van den Hondel D.
        • et al.
        Sensorineural hearing loss and language development following neonatal extracorporeal membrane oxygenation.
        Pediatric Critical Care Medicine. 2013; 14: 62-69
        • Khambekar K.
        • et al.
        Developmental outcome in newborn infants treated for acute respiratory failure with extracorporeal membrane oxygenation: present experience.
        Archives of Disease in Childhood-Fetal and Neonatal Edition. 2006; 91: F21-F25
      6. The collaborative UK ECMO trial: Follow-up to 1 year of age.
        Pediatrics. 1998; 101: e1
      7. Maclaren, G., Extracorporeal life support: The ELSO Red Book, 6th edition. 2022.

        • Bennett C.C.
        • et al.
        UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation: follow-up to age 4 years.
        The Lancet. 2001; 357: 1094-1096
        • McNally H.
        • et al.
        United Kingdom collaborative randomized trial of neonatal extracorporeal membrane oxygenation: follow-up to age 7 years.
        Pediatrics. 2006; 117: e845-e854
        • Dhar A.V.
        • et al.
        Neurodevelopmental Outcomes in Extracorporeal Membrane Oxygenation Patients: A Pilot Study.
        Asaio j. 2020; 66: 447-453
        • Farhat A.
        • et al.
        Routine Neuroimaging: Understanding Brain Injury in Pediatric Extracorporeal Membrane Oxygenation.
        Crit Care Med. 2022; 50: 480-490
        • Madderom M.J.
        • et al.
        Neonatal extracorporeal membrane oxygenation: impaired health at 5 years of age.
        Pediatric Critical Care Medicine. 2013; 14: 183-193
        • Ingyinn M.
        • et al.
        Altered cerebrovascular responses after exposure to venoarterial extracorporeal membrane oxygenation: role of the nitric oxide pathway.
        Pediatr Crit Care Med. 2006; 7: 368-373
        • Hanekamp M.N.
        • et al.
        Follow-up of newborns treated with extracorporeal membrane oxygenation: a nationwide evaluation at 5 years of age.
        Critical Care. 2006; 10: R127
        • Rais-Bahrami K.
        • et al.
        Neurodevelopmental outcome in ECMO vs near-miss ECMO patients at 5 years of age.
        Clinical pediatrics. 2000; 39: 145-152
        • Madderom M.J.
        • et al.
        Neurodevelopmental, educational and behavioral outcome at 8 years after neonatal ECMO: a nationwide multicenter study.
        Intensive care medicine. 2013; 39: 1584-1593
      8. UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. UK Collaborative ECMO Trail Group.
        Lancet. 1996; 348: 75-82
        • Leeuwen L.
        • et al.
        Risk Factors of Impaired Neuropsychologic Outcome in School-Aged Survivors of Neonatal Critical Illness.
        Crit Care Med. 2018; 46: 401-410
        • Madderom M.J.
        • et al.
        Growing Up After Critical Illness: Verbal, Visual-Spatial, and Working Memory Problems in Neonatal Extracorporeal Membrane Oxygenation Survivors.
        Crit Care Med. 2016; 44: 1182-1190
        • Engle W.A.
        • et al.
        Adult Outcomes After Newborn Respiratory Failure Treated With Extracorporeal Membrane Oxygenation.
        Pediatr Crit Care Med. 2017; 18: 73-79
        • Davidson M.C.
        • et al.
        Development of cognitive control and executive functions from 4 to 13 years: Evidence from manipulations of memory, inhibition, and task switching.
        Neuropsychologia. 2006; 44: 2037-2078
        • Schiller R.M.
        • et al.
        Working Memory Training Following Neonatal Critical Illness: A Randomized Controlled Trial.
        Crit Care Med. 2018; 46: 1158-1166
        • Lequier L.
        • et al.
        Two-year survival, mental, and motor outcomes after cardiac extracorporeal life support at less than five years of age.
        J Thorac Cardiovasc Surg. 2008; 136: 976-983 e3
        • Hamrick S.E.
        • et al.
        Neurodevelopmental outcome of infants supported with extracorporeal membrane oxygenation after cardiac surgery.
        Pediatrics. 2003; 111: e671-e675
        • Ibrahim A.E.
        • et al.
        Long-term follow-up of pediatric cardiac patients requiring mechanical circulatory support.
        Ann Thorac Surg. 2000; 69: 186-192
        • Schiller R.M.
        • et al.
        Neonatal critical illness and development: white matter and hippocampus alterations in school-age neonatal extracorporeal membrane oxygenation survivors.
        Dev Med Child Neurol. 2017; 59: 304-310
        • Chao B.K.
        • et al.
        Decreased Brain Volumes and Infants With Congenital Heart Disease Undergoing Venoarterial Extracorporeal Membrane Oxygenation.
        Pediatr Crit Care Med. 2020; 21: 738-745
        • Cashen K.
        • et al.
        Functional Status of Neonatal and Pediatric Patients After Extracorporeal Membrane Oxygenation.
        Pediatr Crit Care Med. 2017; 18: 561-570
        • Elias M.D.
        • et al.
        Long-Term Outcomes of Pediatric Cardiac Patients Supported by Extracorporeal Membrane Oxygenation.
        Pediatr Crit Care Med. 2017; 18: 787-794
        • Barrett C.S.
        • et al.
        Neurological injury after extracorporeal membrane oxygenation use to aid pediatric cardiopulmonary resuscitation.
        Pediatr Crit Care Med. 2009; 10: 445-451
        • Meert K.L.
        • et al.
        Extracorporeal Cardiopulmonary Resuscitation: One-Year Survival and Neurobehavioral Outcome Among Infants and Children With In-Hospital Cardiac Arrest.
        Crit Care Med. 2019; 47: 393-402
        • Cooper J.M.
        • et al.
        Neonatal hypoxia, hippocampal atrophy, and memory impairment: evidence of a causal sequence.
        Cerebral cortex. 2015; 25: 1469-1476
        • Lago P.
        • et al.
        MRI, MRA, and neurodevelopmental outcome following neonatal ECMO.
        Pediatr Neurol. 1995; 12: 294-304
        • Blair L.M.
        • Pickler R.H.
        • Anderson C.
        Integrative Review of Genetic Factors Influencing Neurodevelopmental Outcomes in Preterm Infants.
        Biol Res Nurs. 2016; 18: 127-137
        • Hackman D.A.
        • Farah M.J.
        • Meaney M.J.
        Socioeconomic status and the brain: mechanistic insights from human and animal research.
        Nat Rev Neurosci. 2010; 11: 651-659
        • Herrup E.A.
        • Wieczorek B.
        • Kudchadkar S.R.
        Characteristics of postintensive care syndrome in survivors of pediatric critical illness: A systematic review.
        World J Crit Care Med. 2017; 6: 124-134
        • Choong K.
        • et al.
        Functional Recovery in Critically Ill Children, the "WeeCover" Multicenter Study.
        Pediatr Crit Care Med. 2018; 19: 145-154
        • Davidson A.
        • Flick R.P.
        Neurodevelopmental implications of the use of sedation and analgesia in neonates.
        Clin Perinatol. 2013; 40: 559-573
        • Reiterer F.
        • et al.
        Neonatal Extracorporeal Membrane Oxygenation Due to Respiratory Failure: A Single Center Experience Over 28 Years.
        Front Pediatr. 2018; 6: 263
      9. Madderom, M., Long-term follow-up of children treated with neonatal extracorporeal membrane oxygenation: neuropsychological outcome. 2013: Erasmus MC: University Medical Center Rotterdam.

        • Hordijk J.A.
        • et al.
        Neurocognitive functioning and health-related quality of life of children after pediatric intensive care admission: a systematic review.
        Qual Life Res. 2022; 31: 2601-2614
        • Wray J.
        • et al.
        Childhood Extracorporeal Membrane Oxygenation Survivors: Parents Highlight Need for Structured Follow-Up and Support After Hospital Discharge.
        Pediatr Crit Care Med. 2020; 21: 461-468
        • Sakurai K.
        • Singhal N.
        Extracorporeal membrane oxygenation in children: A brief review.
        J Paediatr Child Health. 2022; 58: 1525-1531
        • Sreeram II,
        • et al.
        Patient-Reported Outcome Measures and Clinical Outcomes in Children with Foregut Anomalies.
        Children (Basel). 2021; 8
        • Fayed N.
        • Cohen E.
        • Houtrow A.
        Quality of life cannot be predicted from a brain scan.
        Developmental Medicine and Child Neurology. 2020; 62 (412): 412
        • Lewis A.R.
        • et al.
        Parental symptoms of posttraumatic stress after pediatric extracorporeal membrane oxygenation*.
        Pediatr Crit Care Med. 2014; 15: e80-e88
        • Williams C.N.
        • et al.
        Long-term Sequelae of Pediatric Neurocritical Care: The Parent Perspective.
        J Pediatr Intensive Care. 2018; 7: 173-181
        • Nieves H.
        • Clements-Hickman A.
        • Davies C.C.
        Effect of a Parent Empowerment Program on Parental Stress, Satisfaction, and Length of Stay in the Neonatal Intensive Care Unit.
        J Perinat Neonatal Nurs. 2021; 35: 92-99
        • Barbaro R.P.
        • Brodie D.
        • MacLaren G.
        Bridging the Gap Between Intensivists and Primary Care Clinicians in Extracorporeal Membrane Oxygenation for Respiratory Failure in Children: A Review.
        JAMA Pediatr. 2021; 175: 510-517